Responses
Other content recommended for you
- Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trials
- Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia
- Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
- Therapeutic interventions increasing seizure risk in multiple sclerosis: resolving discordant meta-analyses
- Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline
- Surveillance patterns of cervical cancer patients treated with conization alone
- WHO should adjust its global strategy for cervical cancer prevention
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
- Protecting people with multiple sclerosis through vaccination